6:45 AM
More on Williams-Sonoma's (WSM) Q1: Brand revenue gain of 5.4% led by West Elm brand and Pottery Barn, offsetting declines at PBteen, Williams-Sonoma, and Pottery Barn Kids. Operating margin falls to 6.0% from 6.7% last year. Sees FY12 EPS of $2.42-$2.49, up from prior guidance of $2.37-$2.47. Expects FY12 revenue of $3.95B-$4.02B, just above the prior estimate of $3.93B-$4.02B. (PR)
Comment!
5:51 AM
More on Vodafone (VOD) earnings: Takes impairment charge of £4B related to Southern Europe ops vs. £6.15B last year. Forecasts this FY's adjusted op profit at £11.1B-£11.9B vs. £11.5B last FY. Raises dividend 7% to 9.52 pence, excluding Verizon Wireless payout.
1 Comment
5:40 AMVodafone (VOD): FY 2011/2012 EBITDA -1.3% to £14.48B vs. forecasts of £14.5B; revenue +1.2% to £46.42B vs. $46.2B; net profit -13% to £6.96B. Shares +1.85% in London. (PR)
Comment!
4:56 PM
More on Urban Outfitters (URBN): Q1 beats on a per share basis but misses slightly on revenue. Net earnings fell 8.6% Y/Y on weaker margins and higher overhead costs, but were still better than Street expectations as same-store sales improved. Shares +7% AH.
Comment!
4:41 PMChinaCache International (CCIH): Q1 EPS of $0.06 may not be comparable to consensus of $0.05. Revenue of $28.9M (+38.9% Y/Y) beats by $8M. (PR)
Comment!
1:22 PM
Youku.com (YOKU +9.8%) and Tudou (TUDO +10.1%), whose planned merger will create a Chinese online video giant, rally strongly following Tudou's Q1 beat. Tudou's revenue surged thanks to a 63% Y/Y increase in online ad sales, and a 53% increase in mobile service sales. However, in a sign monetization may be lagging traffic growth, bandwidth costs amounted to 51% of revenue, up from 39% in the year-ago period. (PR)
Comment!
11:44 AM
Humana (HUM +1.4%) cuts Q2 and FY guidance, citing costs to resolve a previously disclosed lawsuit. For Q2 it expects EPS of $1.98-$2.08 vs. $2.15-$2.25 previously and $2.27 consensus. For the FY it forecasts $7.38-$7.58 vs. $7.55-$7.75 and $7.92 consensus.
Comment!
11:24 AM
Dara Biosciences (DARA -2.3%)) slips after reporting a Q1 net loss of $2M, or $0.29 cents per share, compared to a net loss of $1.3M, or $0.26 cents per share in the same period last year. The higher net loss was due primarily to business acquisition costs and the hiring of experienced staff to help execute its new oncology-focused business strategy.
Comment!
